Log in to your Inderes Free account to see all free content on this page.
Coloplast
410.40 DKK
+1.46 %
Less than 1K followers
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+1.46 %
-7.32 %
-23.63 %
-24.89 %
-33.25 %
-41.03 %
-58.12 %
-60.08 %
+775.05 %
Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Read moreMarket cap
93.65B DKK
Turnover
134.33M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.5.
2026
Interim report Q2'26
18.8.
2026
Interim report Q3'26
3.11.
2026
Annual report '26
All
Press releases
ShowingAll content types
Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis
Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio